Retatrutide
Retatrutide injectable
RETA is a retatrutide injectable offered in 10mg and 30mg vial sizes for provider-directed metabolic care.
People also buy
GLOW GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg)
HCG
Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone that has been widely studied for its role in the reproductive and endocrine systems, including the regulation of sex hormone production. For research use only.
SemaMelt
Semaglutide/Pyridoxine 10mg sublingual tablet
SemaTirzeMelt
Semaglutide + Tirzepatide sublingual tablet
TirzMelt
1 pill a day
AOD-9604 (Reconstituted) - 10mg
Reconstituted at 10mg / 4mL
Tirz (GLP-2)
Lyophilized *MUST BE RECONSTITUTED* Tirz (GLP-2), a synthetic derivative of gastric inhibitory polypeptide (GIP), exhibits simultaneous gluc
Sema (GLP-1)
Lyophilized *MUST BE RECONSTITUTED* Introducing Sema (GLP-1), a powerful peptide designed for research. As a synthetic glucagon-like peptide
References
- Retatrutide - Peptide Center guide
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 TrialThe New England journal of medicine, 2023
- Retatrutide-A Game Changer in Obesity PharmacotherapyBiomolecules, 2025
- Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trialsDiabetes, obesity & metabolism, 2026
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USALancet (London, England), 2023
- Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trialNature medicine, 2024
- The power of three: Retatrutide's role in modern obesity and diabetes therapyEuropean journal of pharmacology, 2024
Ready to start with Retatrutide?
Take our eligibility quiz to see if this treatment is right for you.
Start Intake